Riskpilot← Back to searchSign inGet full accessWAMALINO GROUP AS
ASIn liquidationOrg 925323365Gjerdrums Vei 8, 0484 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20203 employees
Revenue 2024
NOK 4,7M
-28% vs 2023
EBITDA margin
-89.1%
+31% vs 2023
Equity ratio
41.3%
Financial strength
Net profit 2024
NOK 1,9M
+137% vs 2023
| Revenue | NOK 4,7M | -28% |
| EBITDA | NOK -4,2M | +31% |
| Net profit | NOK 1,9M | +137% |
| Total assets | NOK 60,5M | -36% |
| Equity | NOK 24,9M | -36% |
| Employees | 3 | — |
Legal name
WAMALINO GROUP AS
Org number
925323365
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9. juli 2020
Share capital
NOK 1 000 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i aksjer, verdipapirer og fast eiendom samt hva hermed står i forbindelse, herunder deltakelse i andre selskaper med lignende virksomhet.
Address
Gjerdrums Vei 8, 0484 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 60 | 2 128 | 6 538 | 4 675 |
| Staff expenses | −672 | −2 590 | −6 286 | −7 849 | −2 662 |
| EBITDA | −740 | −2 833 | −7 402 | −6 076 | −4 166 |
| Depreciation & amort. | −0 | −0 | −35 | −155 | −155 |
| EBIT | −740 | −2 833 | −7 437 | −6 231 | −4 321 |
| Net financials | 5 843 | 10 864 | 1 524 | 1 134 | 6 216 |
| Profit before tax | 5 102 | 8 032 | −5 913 | −5 097 | 1 895 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 5 102 | 8 032 | −5 913 | −5 097 | 1 895 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 68 729 | 83 490 | 85 854 | 94 114 | 60 471 |
| Equity | 45 188 | 53 220 | 44 307 | 39 210 | 24 947 |
| Long-term debt | 19 000 | 15 006 | 11 000 | 7 657 | 2 800 |
| Short-term debt | 4 541 | 15 264 | 30 547 | 47 247 | 32 724 |
| Total debt | 23 541 | 30 269 | 41 547 | 54 904 | 35 524 |
EBITDA margin
-89.1%
This company
15.8%
Market median
-664% vs market
20202024
Equity ratio
41.3%
This company
38.2%
Market median
+8% vs market
20202024
Return on equity
7.6%
This company
18.4%
Market median
-59% vs market
20202024
Net profit margin
40.5%
This company
8.1%
Market median
+400% vs market
20202024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20202024
Debt / equity
1.42×
This company
0.62×
Market median
-129% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-06-08 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LP Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
DN | Board of Directors | 2020 |
| Former (1) | ||
| Chairman | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 36% | 36% | 2024 | |
| Company | 36% | 36% | 2024 | |
| Company | 33.5% | 33.5% | 2023 | |
| Company | 28% | 28% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Da-No Holding As
WAMALINO GROUP AS Board members of WAMALINO GROUP AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Petter Waldø-Jensen | Chief Executive Officer | 0 companies |
| Jørgen Lindberg | Chairman | 0 companies |
| Dag Nord | Board of Directors | 0 companies |
| Rune Martini | Chairman | 0 companies |